440 related articles for article (PubMed ID: 32607303)
1. Telogen Effluvium: A Review of the Literature.
Asghar F; Shamim N; Farooque U; Sheikh H; Aqeel R
Cureus; 2020 May; 12(5):e8320. PubMed ID: 32607303
[TBL] [Abstract][Full Text] [Related]
2. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM
JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790
[TBL] [Abstract][Full Text] [Related]
3. Telogen effluvium after allergic contact dermatitis of the scalp.
Tosti A; Piraccini BM; van Neste DJ
Arch Dermatol; 2001 Feb; 137(2):187-90. PubMed ID: 11176691
[TBL] [Abstract][Full Text] [Related]
4. Localized Telogen Effluvium Following Hair Transplantation.
Loh SH; Lew BL; Sim WY
Ann Dermatol; 2018 Apr; 30(2):214-217. PubMed ID: 29606820
[TBL] [Abstract][Full Text] [Related]
5. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 infection is a major cause of acute telogen effluvium.
Sharquie KE; Jabbar RI
Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
[TBL] [Abstract][Full Text] [Related]
7. Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation.
Daly T; Daly K
J Drugs Dermatol; 2018 Nov; 17(11):1236-1240. PubMed ID: 30500148
[TBL] [Abstract][Full Text] [Related]
8. Chronic telogen effluvium.
Whiting DA
Dermatol Clin; 1996 Oct; 14(4):723-31. PubMed ID: 9238330
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study.
Perera E; Sinclair R
F1000Res; 2017; 6():1650. PubMed ID: 29167734
[No Abstract] [Full Text] [Related]
10. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
Feaster B; Onamusi T; Cooley JE; McMichael AJ
Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
[TBL] [Abstract][Full Text] [Related]
11. Telogen effluvium: a comprehensive review.
Rebora A
Clin Cosmet Investig Dermatol; 2019; 12():583-590. PubMed ID: 31686886
[TBL] [Abstract][Full Text] [Related]
12. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
[TBL] [Abstract][Full Text] [Related]
13. A novel cosmetic approach to treat thinning hair.
Davis MG; Thomas JH; van de Velde S; Boissy Y; Dawson TL; Iveson R; Sutton K
Br J Dermatol; 2011 Dec; 165 Suppl 3():24-30. PubMed ID: 22171682
[TBL] [Abstract][Full Text] [Related]
14. Acute telogen effluvium triad after resolution.
Contin LA; Rocha VB
An Bras Dermatol; 2021; 96(5):605-608. PubMed ID: 34272075
[TBL] [Abstract][Full Text] [Related]
15. Intermittent Chronic Telogen Effluvium.
Rebora A
Skin Appendage Disord; 2017 Mar; 3(1):36-38. PubMed ID: 28612000
[TBL] [Abstract][Full Text] [Related]
16. Ischemia-modified albumin as a possible marker of oxidative stress in patients with telogen effluvium.
Savci U; Senel E; Oztekin A; Sungur M; Erel O; Neselioglu S
An Bras Dermatol; 2020; 95(4):447-451. PubMed ID: 32482549
[TBL] [Abstract][Full Text] [Related]
17. Anagen effluvium.
Kanwar AJ; Narang T
Indian J Dermatol Venereol Leprol; 2013; 79(5):604-12. PubMed ID: 23974578
[TBL] [Abstract][Full Text] [Related]
18. Chronic telogen effluvium: a study of 5 patients over 7 years.
Sinclair R
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):12-6. PubMed ID: 15692504
[TBL] [Abstract][Full Text] [Related]
19. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women.
Whiting DA
J Am Acad Dermatol; 1996 Dec; 35(6):899-906. PubMed ID: 8959948
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
